Abstract
dc:descriptionRecurrent miscarriage (RM), defined as three or more (or two or more) consecutive miscarriages before 20 weeks, affects (depending on the definition) 1-5% of couples. In the present studywe analysed a sample of 120 patients with >2 miscarriages before 20 gestational weeks for proven and likely causes of recurrent miscarriage and, when indicated, we compared the prevalence ofthe factors under study with that of a control group including women with >2 successful pregnancies without a history of pregnancy loss. The research arm included investigation for thrombophilic mutations (factor II G20210A mutation, Factor V Leiden, Factor V A1299H(A4070G) mutation of HR2 haplotype, MTHFR C677T polymorphism and MTHFR A1298C polymorphism) and for abnormalities of the mechanism of clotting - fibrinolysis (PAI activityand PAI-1 4G/5G polymorphism). One or more accepted causes for recurrent miscarriage were found in 25.8% of the cases. None of the five common thrombophilic mutations under study (factor II G20210A mutation, Factor V Leiden, Factor V A1299H (A4070G) mutation of HR2 haplotype, MTHFR C677T polymorphism and MTHFR A1298C polymorphism) was associated with statisticallyincreased risk for recurrent miscarriage. Factor V Leiden (OR 1.75, 95% CI 0.41 - 7.55) and factor II G20210A mutation (OR 2.63, 95% CI 0.49 - 13.90) are two possible exceptions to this; however, the small size of our sample prevented them from reaching statistical significance. The activity of PAI was not significantly different between the groups (p=0.61). However, the distribution of PAI-1 4G/5G polymorphism was significantly different (p=0.01) and homozygosity 4G/4G was more common among controls (p=0.014). Linear regression analysis showed that protein C level, homozygosity 4G/4G and age are the only significant predictors for PAI activity. Protein C level accounts for 22% of the variability in PAI activity and 4G/4G haplotype for only 6%. No responsible causative factor was found in 74.2% (95% CI 66.3 - 82.0) of our patients. Forty-one patients from this subgroup achieved pregnancy, for which the outcome is known, within the first year after investigation. Excluding two cases of ectopic pregnancy, the overall successful pregnancy rate was 79.5% (95% CI 66.8- 92.1). Although the small size of this sample prevents formal statistical analysis, a simple descriptive analysis indicates that the prognosis in a subsequent pregnancy is mainly associated with the age of the patient and the number of previous miscarriages.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sotiriadis, Alexandros
- Σωτηριάδης, Αλέξανδρος
Subjects
dc:subject × 15- Αποβολές, Καθ' έξιν
- Θρομβοφιλία
- Παράγοντας V Leiden
- Προθρομβίνη
- Αναστολέας του ενεργοποιητή του πλασμινογόνου (ΡΑΙ-1)
- Miscarriage, Recurrent
- Thrombophilia
- Factor V Leiden
- Prothrombin
- MTHFR
- Plasminogen activator inhibitor
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21095